The BRF was established in 1988 and has a long history of DNA sequencing, with a number of instrument upgrades since that time. In 2003 the facility installed an Applied Biosystems 48 capillary 3730 DNA Analyzer. This was upgraded to 96 capillaries in 2010.
The facility operates on a ‘cost recovery’ basis and we aim for a turnaround time of 1-3 days from receipt of samples for User Prep samples and five working days for Core Prep samples. Internal controls are included in all sequencing runs and our pGem controls routinely produce over 1,000 base pairs of data with a quality score of >20.
Our commitment to our customers is to provide excellent service, accurate results, fast turnaround times, at low cost.
- Customer completed reactions (user prep)
- Sequencing reactions performed by BRF (core prep)
(capillary electrophoresis service only)
- Microsatellite analysis
- AFLP analysis
- RFLP analysis
The quality of the data is determined by the quality and quantity of the DNA template and primer that you use. Sample cleanup is critical as large excess Big Dye blobs will saturate the signal and salt will prevent correct electrokinetic injection.
Price for ANU clients
Price is calculated and quoted when you order via dnaLIMS.
Price for external clients
External organisation (non-profit)
External organisation (commercial)
|Project in 96 well plates||Please contact BRF||Please contact BRF|
|Genotyping (MS, SNP, frag analysis)||$7.10||$9.10|
|Genotyping project in 96 well plates||Please contact BRF||Please contact BRF|
Please complete the electronic DNA sequencing order form via dnaLIMS and submit a signed copy of the summary with your samples to BRF room 2.043 (Sample Drop Off). Samples will not be analysed until submitted electronically.
Make sure the person who is authorised to sign on your account, signs the summary form before bringing it to the facility.
It is not advisable to use internal mail to send samples as the internal mail is not sorted on campus and can take up to one week to arrive. If you are posting samples, please use Express Post bags and wrap samples in bubble wrap to protect tubes. Sample status can be tracked via the dnaLIMS system using your order number. Big Dye and buffer can be purchased via dnaLIMS and collected from reception at BRF.
1. The BRF operates on a cost recovery basis. The percentage of subsidization is determined by The John Curtin School of Medical Research.
2. No samples or orders will be processed without an authorised* sample submission/order form and valid charge code. (*Authorised by the signature of the PI/Lab Head, or by granting of electronic access to BRF ordering systems with the authority of the PI/Lab Head).
3. It is a condition of the contract between the ACRF and JCSMR/ANU that "the Foundation (ACRF) is to be acknowledged in all scientific publications which utilise the Facility (BRF) at the Institute (JCSMR)". All work performed in the BRF, whether full service or not, and the use of any BRF resources should be acknowledged in all publications arising from that work. This should be in the “Material and Methods” section of the paper (see examples below). Any further individual acknowledgements are solely at your discretion.
4. A reference to the publication should be sent to the Manager of the BRF once the paper is published (includes theses).
5. BRF collaborations and co-authorship: although the BRF is primarily a service unit, there are instances where BRF staff make significant contributions to either the technical or intellectual input of the project. This should be discussed with the staff member concerned prior to the commencement of the collaboration.
Consumables and data
- The customer agrees to cover the cost of any consumables ordered on their behalf if the customer fails to supply the correct quantity and quality of the starting material required for processing. Details of the quality and quantity required are on the BRF website and sample submission form.
- Customers are responsible for archiving data generated by the BRF. Data generated by the BRF are solely for the use of the customer and their collaborators. Data is not to be sold to a third party. The BRF shall not be responsible for data output generated from samples that deviate from recommended protocols as requested by the customer.
- Upon receipt of consumables and/or data, the customer accepts responsibility for the correct handling, use, storage and disposal of the consumables/data.
- The BRF extends no warranties of any kind in respect to the consumables. Any consumables sold may have hazardous properties. The customer agrees to use appropriate caution and safeguards as not all properties are known.
- Consumables sold by the BRF shall not be transferred to another party without the written consent of the BRF. The BRF is not responsible for any losses arising from the use of consumables. The BRF will not be liable to the customer for any loss, claim or demand made by the customer due to acceptance, handling, use, storage or disposal of consumables and/or data by the customer, except to the extent permitted by law when it is the result of willful misconduct on the part of the BRF or its employees.
Acknowledgement in Publications
“Amplifications were performed in 384-well optical reaction plates (Applied Biosystems) with a 7900HT Fast Real-Time PCR System at the Genome Discovery Unit - ACRF Biomolecular Resource Facility, The John Curtin School of Medical Research, Australian National University using SDS 2.4 software to analyse raw data.”
DNA Sanger Sequencing
Amplified PCR products were purified and sequenced on an AB 3730xl DNA Analyzer (at the Genome Discovery Unit - ACRF Biomolecular Resource Facility, The John Curtin School of Medical Research, Australian National University) following the manufacturer's protocol (Applied Biosystems 2002).”
Peptides were synthesized chemically using the 9-fluorenylmethyloxycarbonyl (Fmoc) method on a CEM Microwave-assisted Peptide Synthesizer and purified by one round of C18 reversed-phase HPLC by the Genome Discovery Unit - ACRF Biomolecular Resource Facility at the John Curtin School of Medical Research, Australian National University. As required, the N- or C-terminus, or both, were protected by acetylation or amidation, respectively.”
Cells were surface stained with APC-labelled tetramers consisting of murine class I MHC molecule (H-2Db), b2-microglobulin and influenza nucleoprotein peptide NP366–374. Tetramers were synthesised at the Genome Discovery Unit - ACRF Biomolecular Resource Facility at The John Curtin School of Medical Research, Australian National University using BirA enzyme synthesized as described (O’Callaghan et al., 1999). [O’Callaghan, C.A., Byford, M.F., Wyer, J.R., Willcox, B.E., Jakobsen, B.K., McMichael, A.J. and Bell, J.I (1999). BirA Enzyme: Production and Application in the study of membrane receptor-ligand interactions by site-specific biotinylation.Anal. Biochem. 266, 9-15.]”